Single-molecule Kinetics: TIRF based Fluorescence microscopy and FRET studies.
Organic Synthesis: Solution based small molecule & Enzyme-catalyzed synthesis.
Drug Design & action: Active-site directed mechanism-based inhibitor design.
Spectroscopy: Fluorescence, FRET, UV-visible, NMR, IR & CD spectroscopy.
Mass Spectrometry: GC-MS, LC-MS
Chromatography: Ion-exchange, gel filtration, metal-affinity, HPLC, FPLC.
Gel Electrophoresis: Agarose and polyacrylamide (Native and denaturing) gels.
Molecular Modeling: Sungraphics; Unix based Insight II Package
Molecular Biology: Bacterial expression of proteins; Gene cloning; mutagenesis.
Senthil Perumal's Summary
Senthil Perumal, based in California, United States, is currently a Director at Scorpion Therapeutics, bringing experience from previous roles at Merck, IDEAYA Biosciences and GenapSys, Inc.. Senthil Perumal holds a M. Sc in Chemistry @ Indian Institute of Technology, Madras. With a robust skill set that includes Enzyme Kinetics: Steady state, Pre-steady state, Stopped-flow, inhibition., Single-molecule Kinetics: TIRF based Fluorescence microscopy and FRET studies., Organic Synthesis: Solution based small molecule & Enzyme-catalyzed synthesis., Drug Design & action: Active-site directed mechanism-based inhibitor design., Spectroscopy: Fluorescence, FRET, UV-visible, NMR, IR & CD spectroscopy. and more, Senthil Perumal contributes valuable insights to the industry. Senthil Perumal has 1 email on RocketReach.